# Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis

> **NCT06994130** · — · NOT_YET_RECRUITING · sponsor: **ImCare Biotech** · enrollment: 1392 (estimated)

## Conditions studied

- Hepatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Seravue

## Key facts

- **NCT ID:** NCT06994130
- **Lead sponsor:** ImCare Biotech
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08
- **Primary completion:** 2028-08
- **Final completion:** 2029-08
- **Target enrollment:** 1392 (ESTIMATED)
- **Last updated:** 2025-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06994130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06994130, "Seravue Validation Study for Hepatocellular Carcinoma (HCC) Diagnosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06994130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*